Efficacy of IST according to selected observational studies
| Study . | N . | Median age, y . | Partial remission . | Complete remission . | 
|---|---|---|---|---|
| EACH2 registry26 | 294 | 75 | NR | GC: 58% GC + Cy: 80% GC + Ri: 64% | 
| GTH-AH 01/201012 | 102 | 74 | 83% | 61% | 
| Spanish registry14 | 151 | 74 | NR | 84% | 
| Dutch cohort study13 | 143 | 73 | NR | 79% | 
| Chinese national registry27 | 187 | 52 | GC: 70% GC + Cy: 92% | GC: 49% GC + Cy: 83% | 
| Budapest (CyDRi)20 | 32 | 77 | NR | 91% | 
| Study . | N . | Median age, y . | Partial remission . | Complete remission . | 
|---|---|---|---|---|
| EACH2 registry26 | 294 | 75 | NR | GC: 58% GC + Cy: 80% GC + Ri: 64% | 
| GTH-AH 01/201012 | 102 | 74 | 83% | 61% | 
| Spanish registry14 | 151 | 74 | NR | 84% | 
| Dutch cohort study13 | 143 | 73 | NR | 79% | 
| Chinese national registry27 | 187 | 52 | GC: 70% GC + Cy: 92% | GC: 49% GC + Cy: 83% | 
| Budapest (CyDRi)20 | 32 | 77 | NR | 91% | 
Cy, cyclophosphamide; GC, glucocorticoid; NR, not reported; Ri, rituximab.